29.50
Usana Health Sciences Inc stock is traded at $29.50, with a volume of 255.34K.
It is up +1.10% in the last 24 hours and up +16.69% over the past month.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
See More
Previous Close:
$29.18
Open:
$29.16
24h Volume:
255.34K
Relative Volume:
1.13
Market Cap:
$555.24M
Revenue:
$861.97M
Net Income/Loss:
$54.34M
P/E Ratio:
10.42
EPS:
2.83
Net Cash Flow:
$65.64M
1W Performance:
+0.20%
1M Performance:
+16.69%
6M Performance:
-26.71%
1Y Performance:
-36.31%
Usana Health Sciences Inc Stock (USNA) Company Profile
Name
Usana Health Sciences Inc
Sector
Industry
Phone
(801) 954-7100
Address
3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT
Compare USNA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
USNA
Usana Health Sciences Inc
|
29.50 | 555.24M | 861.97M | 54.34M | 65.64M | 2.83 |
![]()
KHC
Kraft Heinz Co
|
28.07 | 33.90B | 25.85B | 2.74B | 3.02B | 2.26 |
![]()
GIS
General Mills Inc
|
54.50 | 30.35B | 19.64B | 2.56B | 2.48B | 4.55 |
![]()
K
Kellanova
|
82.48 | 28.75B | 12.63B | 1.38B | 863.00M | 3.96 |
![]()
MKC
Mccormick Co Inc
|
76.07 | 20.39B | 6.68B | 792.60M | 774.40M | 2.94 |
![]()
HRL
Hormel Foods Corp
|
29.21 | 16.12B | 11.92B | 805.04M | 1.01B | 1.46 |
Usana Health Sciences Inc Stock (USNA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-23-23 | Initiated | Sidoti | Buy |
Jul-07-22 | Downgrade | Jefferies | Hold → Underperform |
Apr-14-22 | Initiated | DA Davidson | Neutral |
Dec-17-20 | Initiated | ROTH Capital | Buy |
Aug-22-19 | Initiated | Jefferies | Hold |
Apr-16-19 | Initiated | Tigress Financial | Buy |
Oct-25-18 | Upgrade | Sidoti | Neutral → Buy |
Oct-24-18 | Upgrade | Pivotal Research Group | Hold → Buy |
Apr-23-18 | Downgrade | Pivotal Research Group | Buy → Hold |
Feb-07-18 | Reiterated | Pivotal Research Group | Buy |
Jan-24-18 | Downgrade | Sidoti | Buy → Neutral |
Oct-25-17 | Reiterated | Pivotal Research Group | Buy |
Jul-26-17 | Reiterated | Pivotal Research Group | Buy |
May-03-17 | Upgrade | Pivotal Research Group | Hold → Buy |
May-01-17 | Downgrade | Pivotal Research Group | Buy → Hold |
Feb-08-17 | Reiterated | Pivotal Research Group | Buy |
Jul-28-16 | Reiterated | DA Davidson | Neutral |
Feb-10-16 | Downgrade | DA Davidson | Buy → Neutral |
Oct-16-15 | Upgrade | Sidoti | Neutral → Buy |
Sep-16-15 | Upgrade | DA Davidson | Neutral → Buy |
Aug-06-15 | Downgrade | DA Davidson | Buy → Neutral |
Aug-05-15 | Upgrade | Pivotal Research Group | Hold → Buy |
Jun-26-15 | Initiated | DA Davidson | Buy |
View All
Usana Health Sciences Inc Stock (USNA) Latest News
USANA Releases 2024 Sustainability Report - marketscreener.com
USANA HEALTH SCIENCES INC SEC 10-Q Report - TradingView
Kevin Guest Shares Transformative Success Strategies on Executive Coaching Day, May 1 – Company Announcement - Financial Times
USANA Wins Good Housekeeping Beauty Award - Direct Selling News
USANA Celavive Postbiotic Rescue Serum Selected as a Good Housek - GuruFocus
USANA Celavive Postbiotic Rescue Serum Selected as a Good Housekeeping 2025 Beauty Award Winner - marketscreener.com
USANA Health Sciences outlines 2025 product launch plans and Hiya growth strategy - MSN
USANA Q1 2025 presentation highlights: Revenue grows despite profit decline as Hiya integration continues - Investing.com Canada
USANA Health Sciences' (NYSE:USNA) earnings have declined over five years, contributing to shareholders 70% loss - simplywall.st
Press Release Distribution & PR Platform - ACCESS Newswire
USANA Philippines Named Trusted Brand by Reader’s Digest - Direct Selling News
USANA Health Sciences, Inc. (NYSE:USNA) Q1 2025 Earnings Call Transcript - Insider Monkey
USANA Philippines Named One of the Most Trusted Brands by Reader s Digest - MSN
Usana Health Sciences Inc (USNA) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ... By GuruFocus - Investing.com Canada
USANA Health Sciences Sees Sales Growth Amid Earnings Decline - TipRanks
USANA Philippines Named Among Most Trusted Brands by Reader's Digest - The Manila Times
USANA Philippines Named Among Most Trusted Brands by Reader’s Digest - The Malaysian Reserve
USANA’s Strong Start in 2025: Earnings Call Insights - TipRanks
USANA (USNA) Sees Revenue Boost in Q1 Amid Strategic Growth Init - GuruFocus
USANA Reports Q1 2025 Financial Results - Direct Selling News
Earnings call transcript: USANA Health Sciences Q1 2025 results boost stock - Investing.com Australia
USANA Health Sciences posts mixed Q1 results, strong guidance By Investing.com - Investing.com India
USANA Health: Q1 Earnings Snapshot - CTPost
USANA Health Sciences (USNA) Q1 Earnings and Revenues Surpass Estimates - MSN
USANA Health Sciences Q1 Adjusted Earnings Fall, Net Sales Rise; Reiterates 2025 Outlook - marketscreener.com
USANA (NYSE:USNA) Exceeds Q1 Expectations, Full-Year Sales Guidance is Optimistic - Yahoo Finance
USANA (NYSE:USNA) Exceeds Q1 Expectations, Full-Year Sales Guidance Is Optimistic - Barchart.com
USANA Health Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
USANA Health Sciences posts mixed Q1 results, strong guidance - Investing.com Australia
(USNA) Usana Health Sciences Forecasts 2025 Revenue Range $920M$1B - marketscreener.com
USANA Health Sciences Reports First Quarter 2025 Results and Reiterates Full-Year Outlook - Business Wire
Exploring Usana Health Sciences's Earnings Expectations - Benzinga
USANA (USNA) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
USANA stock touches 52-week low at $23.63 amid market challenges - Investing.com Nigeria
USANA stock touches 52-week low at $23.63 amid market challenges By Investing.com - Investing.com South Africa
USANA Clinical Study Shows Promise for Improving Skin Appearance - Direct Selling News
USANA Health Sciences Says Skin Treatment Study Shows Significant Improvements in Appearance - marketscreener.com
Clinical Study Shows USANA Celavive's Resurfacing Serum to Impro - GuruFocus
Clinical Study Shows Usana Celavive's Resurfacing Serum To Improve Appearance Of Skin In Just Two Weeks - marketscreener.com
Clinical Study Shows USANA Celavive's Resurfacing Serum to Improve Appearance of Skin in Just Two Weeks - PR Newswire
Capital Allocation Trends At USANA Health Sciences (NYSE:USNA) Aren't Ideal - Yahoo Finance
Ionis Pharmaceuticals (IONS) Surges 8.9%: Is This an Indication of Further Gains? - Yahoo Finance
USANA Schedules First Quarter 2025 Earnings Release and Conference Call - marketscreener.com
Usana Health Sciences Inc Stock (USNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):